Paloma Partners Management CO 23and Me Holding Co. Transaction History

Paloma Partners Management CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.36 - $0.61 $114,220 - $193,540	317,279 Added 1027.03%	348,172 $135,000
Q1 2024 May 15, 2024	BUY	$0.4 - $0.91 $12,357 - $28,112	30,893 New	30,893 $16,000
Q2 2022 Aug 15, 2022	SELL	$2.19 - $3.98 $183,607 - $333,679	-83,839 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$3.28 - $7.12 $68,466 - $148,622	-20,874 Reduced 19.93%	83,839 $321,000
Q4 2021 Feb 14, 2022	BUY	$6.55 - $13.25 $685,870 - $1.39 Million	104,713 New	104,713 $697,000
Q3 2021 Nov 15, 2021	SELL	$7.29 - $11.0 $157,894 - $238,249	-21,659 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$9.87 - $13.32 $213,774 - $288,497	21,659 New	21,659 $253,000

116

82.5M

404K

292K

Ticker ME
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 259,768,000
Market Cap $795M
Description
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.